| IFNβ-1a 44 mcg three times weekly (n = 48) | IFNβ-1a 22 mcg three times weekly (n = 53) |
---|---|---|
Age (years) | 34.2 ± 8.4 | 35.3 ± 8.2 |
Sex (fem/male) | 30 (62.5%)/18 (37.5%) | 41 (77.4%)/12 (22.6%) |
Age at disease onset | 29.2 ± 8.3 | 30.4 ± 8.1 |
Duration of MS (years) | 5.2 ± 4.3 | 4.9 ± 4.2 |
EDSS score | 1.7 ± 1.0 | 1.6 ± 1.0 |
Annual relapse rate prior to therapy | 0.8 ± 0.9 | 1.0 ± 1.2 |